GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » PB Ratio

Divi's Laboratories (NSE:DIVISLAB) PB Ratio : 11.52 (As of Jun. 20, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-06-20), Divi's Laboratories's share price is ₹6493.00. Divi's Laboratories's Book Value per Share for the quarter that ended in Mar. 2025 was ₹563.87. Hence, Divi's Laboratories's PB Ratio of today is 11.52.

Warning Sign:

Divi's Laboratories Ltd stock PB Ratio (=11.82) is close to 3-year high of 11.95.

The historical rank and industry rank for Divi's Laboratories's PB Ratio or its related term are showing as below:

NSE:DIVISLAB' s PB Ratio Range Over the Past 10 Years
Min: 5.81   Med: 8.43   Max: 14.36
Current: 11.46

During the past 13 years, Divi's Laboratories's highest PB Ratio was 14.36. The lowest was 5.81. And the median was 8.43.

NSE:DIVISLAB's PB Ratio is ranked worse than
93.74% of 926 companies
in the Drug Manufacturers industry
Industry Median: 1.98 vs NSE:DIVISLAB: 11.46

During the past 12 months, Divi's Laboratories's average Book Value Per Share Growth Rate was 10.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 8.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 14.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 15.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Divi's Laboratories was 53.50% per year. The lowest was 8.50% per year. And the median was 18.80% per year.

Back to Basics: PB Ratio


Divi's Laboratories PB Ratio Historical Data

The historical data trend for Divi's Laboratories's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories PB Ratio Chart

Divi's Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.35 9.96 5.87 6.74 10.24

Divi's Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.74 - 10.53 - 10.24

Competitive Comparison of Divi's Laboratories's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Divi's Laboratories's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's PB Ratio distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's PB Ratio falls into.


;
;

Divi's Laboratories PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Divi's Laboratories's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2025)
=6493.00/563.87
=11.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Divi's Laboratories  (NSE:DIVISLAB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Divi's Laboratories PB Ratio Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Divi's Laboratories Business Description

Traded in Other Exchanges
Address
Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines